Results 21 to 30 of about 5,957,667 (290)
Serum total IgG and IgG4 levels in thyroid eye disease
International Medical Case Reports Journal, 2016 Aileen Sy, Rona Z Silkiss Department of Ophthalmology, California Pacific Medical Center, San Francisco, CA, USA Purpose: To investigate the relationship between immunoglobulin G (IgG)4-related disease (IgG4-RD) and thyroid eye disease (TED ...
Sy A, Silkiss RZ
doaj +1 more source
Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
Clinical Case Reports, 2022 A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine.
Solange Grunenwald +4 more
doaj +1 more source
BMC Ophthalmology, 2023 Background Thyroid eye disease is an extrathyroidal manifestation of Graves’ disease and is associated with dry eye disease. This is the first systematic review and meta-analysis to evaluate the role of magnetic resonance imaging lacrimal gland ...
Nicole Tsz Yan Wong +8 more
doaj +1 more source
Canadian Medical Association Journal, 2013 About 90% of patients with thyroid eye disease have Graves hyperthyroidism, but hypothyroidism and euthyroidism can also accompany this condition.[1][1] Eye disease usually develops in patients with hyperthyroidism within the first 1–2 years, but the disease can occur decades later.
Michel J, Belliveau, David R, Jordan
openaire +2 more sources
Horizontal eye position in thyroid eye disease: a retrospective comparison with normal individuals and changes after orbital decompression surgery. [PDF]
PLoS ONE, 2014 To compare horizontal eye positions between proptotic thyroid eye disease patients and normal individuals, and to examine positional changes after orbital decompression surgery in thyroid eye disease patients.The present case-controlled and retrospective
Yasuhiro Takahashi, Hirohiko Kakizaki
doaj +1 more source
The eye and thyroid disease [PDF]
Current Opinion in Ophthalmology, 2008 The pathophysiology and optimal management of thyroid eye disease (TED) have not yet been elucidated. Recent studies have increased our knowledge of the disease process and different diagnostic and therapeutic options. This review highlights the recent progress in TED research and identifies areas requiring further advancements.The pathophysiology of ...
Ajay E, Kuriyan +2 more
openaire +2 more sources
Dry eye syndrome in thyroid-associated ophthalmopathy
Oftalʹmologiâ, 2015 Purpose: The pathogenesis of keratoconjunctivitis sicca in patients with thyroid eye disease is presented. The influence of therapy by a HYLO-PARIN® on a condition of a tear film in patients with various forms of thyroid eye disease is assessed. Methods:
A. F. Brovkina +2 more
doaj +3 more sources
Frontiers in Bioengineering and Biotechnology, 2023 This study replicated the behavior of intraorbital tissue in patients with thyroid eye disease (TED) based on finite element analysis for general orbital decompression risk evaluation in thyroid eye disease patients. The orbit and intraorbital tissues of
Byeong Cheol Jeong +6 more
doaj +1 more source
Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
Frontiers in Endocrinology, 2022 There is currently no universally accepted name for inflammatory disease of the eye and orbit associated with thyroid autoimmune disease. Variability in terminology impedes the evaluation of scientific literature and clinical collaboration and can affect
Lilly H. Wagner +5 more
doaj +1 more source
Journal of Medical Case Reports, 2022 Background Teprotumumab is a novel treatment that reduces inflammation and symptoms caused by thyroid eye disease. There are limited data on teprotumumab’s effect on intraocular pressure.
Matthew Chu +4 more
doaj +1 more source